Pharmacy crime discussed at NCPA conference
PHILADELPHIA Community pharmacists got a briefing about pharmacy security from a company that has learned a lot about it at the National Community Pharmacists Association’s annual Convention and Trade Exposition in Philadelphia.
Purdue Pharma, which makes the prescription opioid painkiller OxyContin (oxycodone), debuted the second annual “RxPatrol Pharmacy Safety and Security” video. Purdue created the video under a partnership with the NCPA as part of the organization’s Protect Your Pharmacy Now! initiative, started in 2008. RxPatrol is a program that Purdue created in May 2003 to track pharmacy crime.
In the video, NCPA member Jim Fields and Purdue director of law enforcement liaison and education Rich Zenuch discuss pharmacy burglary and how to prevent it, touring Fields’ pharmacy in Ft. Smith, Ark., to evaluate his security measures.
“Pharmacy crime affects our customers, our staff and our businesses,” NCPA president Joseph Harmison stated. “As communities across the country experience robberies and burglaries, NCPA is pleased to continue our Protect Your Pharmacy Now! partnership with Purdue’s RxPatrol program to help our members prevent pharmacy crime.”
‘Picture This’ forums bring diabetes management awareness to public
PRINCETON, N.J. A few days after it released a report on how awareness and education play an integral role in the prevention, detection and treatment of diabetes, Novo Nordisk is bringing it to the public.
The drug maker said Friday that, through its collaboration with the Entertainment Industries Council, it will host "Picture This" forums, which include an open discussion among diabetes stakeholders and the media to identify top diabetes communication challenges, explore strategies to address those priorities and strengthen community understanding about diabetes through news media and community affairs programs.
The forums will be held in Philadelphia on Oct. 22 and Seattle on Nov. 18.
"Novo Nordisk is proud to join EIC, the media and community leaders in Seattle and Philadelphia to explore ways to improve how diabetes is communicated about and understood by local citizens," said Tony Deluzio, senior medical director at Novo Nordisk. "As the prevalence of diabetes continues to be on the rise, bringing together those on the front line of diabetes care will open the potential to reduce the stigma associated with diabetes and empower those affected by the disease to lead full and productive lives."
Pfizer makes official tender offer for King
NEW YORK Pfizer officially has made its tender offer to buy King Pharmaceuticals for $3.6 billion, or $14.25 per share, Pfizer said Friday.
The offer constitutes a 40% premium over the closing price of King’s stock on Oct. 11, when Pfizer originally made the offer. King, based in Bristol, Tenn., specializes in pain medications designed to deter misuse and abuse, and Pfizer said the acquisition would enhance its position in the pain-relief market.
The offer expires at midnight on Nov. 19.